Meet the CHILI faculty

 

 

The faculty members of CHILI kindly invite you to join the Conference on Hybrid Imaging Live on October 26.

Some have recorded personal invitation videos (even in their mother language), you can find them here.

 

  Moderator

Karen Coleman (Dublin, Ireland)

Karen is a highly sought-after conference moderator who regularly moderates high-level events. Her experience as a BBC correspondent along with her background presenting live international radio shows and making television documentaries, have given her the skills to handle all sorts of conference moderating requirements.

These can range from conducting interviews on stage with prime ministers and presidents to managing large panel debates and lively interaction with audiences.

Karen has moderated a significant array of events over the years including major international conferences for clients such as the EU Commission, European Parliament, European businesses, Finance and Insurance companies, journalism and environmental organisations, NGOs, etc. The topics she has covered have included Brexit, the Euro crisis, European Smart cities, European finance and economics, Global hunger, Maritime and Environmental policies, Food for the future, Climate Change, Research and Innovation, the Future of Europe, the Digital economy, Digital technologies for the 21st Century.

10:00-11:30

The basics of hybrid imaging

Ivo Rausch (Vienna, Austria)

Ivo Rausch studied Technical Physics at the University of Technology Vienna with a focus on radiation protection and nuclear physics and graduated in 2011. He joined the Division of Nuclear Medicine, Medical University of Vienna as a scientific employee in 2013.  Ivo then joined the Center for Medical Physics and Biomedical Engineering (CMPBMT), where he also accomplished the PhD program in Medical Physics. Further, he completed the University course “Medical Physics” which is compliant with the EFOM and EU guidelines for the education of medical physics experts.

Today, he is a post doc researcher in the Quantitative Imaging and Medical Physics group at the CMPBMT. His interests relate to quantitative hybrid imaging in nuclear medicine with a special focus on PET/MRI and PET/CT. In close collaboration with the Division of Nuclear Medicine, he is engaged in several (clinical) studies and educational activities. He is member of the working group “Medical Physics and radiation protection” of the Austrian society of Nuclear Medicine and Molecular Imaging (OGNMB), member of the ESHI(MT) research committee and Board member of the Austrian Society of Radiation Protection in Medicine (VSMÖ).

José L. Vercher-Conejero (Barcelona, Spain)

José L Vercher Conejero, 41 years old, was born in Valencia, and obtained his Bachelor of Medicine in the University of Lleida (class 98-04). Later, he achieved the specialty degree in Nuclear Medicine at the University and Polytechnic Hospital La Fe in Valencia (HUPL). During his training period of the specialty, for his merits he was awarded a scholarship by the Official College of Physicians of Valencia and invited by the Mount Sinai Medical Hospital of New York to perform a rotation in the Department of Radiology (area of Nuclear Medicine and PET/CT).

Once he got his specialist degree in May 2010, he started working as such in the HUPLF. In 2012 he was selected to carry out a 1-year fellowship in the Department of Radiology at UH Hospital/Case Western Reserve University in Cleveland (Ohio, USA), specializing in PET/MRI and digital PET mainly. After completing the Fellowship, he returned to HUPLF to continue working in the Nuclear Medicine Service, within the Clinical Area of Medical Imaging.

In May 2015 he left the HUPLF and moved to Barcelona to work at the University Hospital of Bellvitge (HUB). Since then, he has been involved in oncology studies in PET/CT. He has also been involved in radiometabolic therapy such as Lutecio-177 for the treatment of neuroendocrine tumours, microspheres with Y-90 for the treatment of intrahepatic tumour lesions, radiosynoviorthesis, among others.

Jean-Noël Talbot (Paris, France)

 

POSITIONS

  • Professor of biophysics and nuclear medicine at University P & M Curie (Paris VI) since 1990
  • Former Head of the nuclear medicine department of University hospital Tenon 1991-2018
  • Expert at the French Medicine Agency (AFSSAPS and HAS) since 1992
  • Chairman of the Scientific Advisory Group “Diagnostic agents” of the European Medicines Evaluation Agency (EMEA

 

DEGREES

  • Medicine Doctor : 20/10/1978 (University P & M. Curie, Paris). Silver medal.
  • Specialist in nuclear medicine in 1979
  • Specialist in endocrinology in 1982
  • Ph D in investigative Endocrinology in 1977
  • Ph D in statistics and methodology of assays in 1978 (Pr Schwartz)
  • Life Science Doctor in 1989 (University P&M Curie, Paris)

 

PUBLICATIONS

  • Over 150 original articles referenced in Pub Med
  • One complete book “Scintigraphie” (Masson publisher),
  • One CD-ROM on FDG CDET
  • 11 Chapters of books, 46 lectures or review articles.
  • H Hirsch factor = 36

11:30-13:00

Clinical applications in hybrid imaging I

Francesca Giunta (Turin, Italy)

Dr. Giunta is currently employed at the nuclear medicine department of the Turin University Hospital. She has authored and co-authored multiple publications, mainly focussing on the use of 18-FDG-PET/CT in the assessment of response to therapy in Lymphomas as well as the use of 18-FDG-PET/CT  in gynaecologic oncology.

Read Dr. Giunta’s CV here.

 

Helle Westergren Hendel (Copenhagen, Denmark)

Chief Physician of Clinical Physiology and Nuclear Medicine at the PET and cyclotrone centre at Herlev Hospital and Clinical Assistant Professor at the University of Copenhagen.

  • Educated at the University of Copenhagen (1991). Underwent speciality training at various hospitals in Copenhagen. Specialist in Nuclear Medicine and Clinical Physiology 2001.
  • Obtained the PhD-degree from university of Copenhagen 1991.
  • Has published more than 50 peer reviewed papers on nuclear medicine.
  • Supervisor/co-supervisor for PhD-students in oncology and PET. The group has studied criteria for treatment monitoring in colorectal cancer, monitoring of immunotherapy in malignant melanoma, and the performance of different tracers in the diagnosis of bone metastases in prostate cancer patients compared with MRI.
  • Has international experience as an expert lecture in PET and oncology from training courses for the International Atomic Energy Agency (since 2006).
  • Has a bachelor in Health Economics.
Christina Pfannenberg (Tübingen, Germany)

Christina Pfannenberg is senior consultant and Associate Professor at the Department of Radiology at the Eberhard-Karls-Universität Tuebingen in Germany.

In close cooperation with the Department of Nuclear Medicine she was instrumental in the installation of the PET/CT-Center in Tüebingen and is continuously engaged in its further development.

Prof. Pfannenberg’s clinical research interests focus on the validation of multimodal oncological imaging strategies, especially on the clinical application of hybrid methods like PET/CT and PET/MRI.


13:00-14:30

Clinical applications in hybrid imaging II

Jann Mortensen (Copenhagen, Denmark)

Jann Mortensen is Clinical Professor of Clinical Physiology and Nuclear Medicine at the University of Copenhagen and Chief Physician of Clinical Physiology and Nuclear Medicine at Rigshospitalet, Copenhagen, Denmark.

He underwent specialty training at various hospitals in the Copenhagen area. He has been Visiting Assistant Professor of Medicine at the University of Illinois at Chicago.

He has published over 195 peer reviewed papers mainly focusing upon theranostics and the lung.

In theranostics, emphasis is upon neuroendocrine tumors and PET/CT imaging with 68Galium-DOTATOC and 64Cobber-DOTATATE PET/CT and treatment with 177Lutetium-Dotatate treatment as well as treatment with 223Radium in prostatic cancer.

His group has been active in optimizing V/Q imaging of Pulmonary Embolism and COPD with SPECT/CT, FDG PET/CT in lung cancer, and assessing radio aerosol lung distribution and mucociliary clearance. Also lung function and pathophysiology is being studied.

Clemens Cyran (Munich, Germany)

Clemens C. Cyran, MD is Professor of Radiology, Section Chief Hybrid and Molecular Imaging and member of the department directorium at the Department of Radiology, Ludwig-Maximilians-University Munich, Germany.

Prof. Cyran completed his residency in radiology in Munich in 2013 and is also board certified in diagnostic nuclear medicine. Prof. Cyran is heading the Subcommittee for Hybrid, Molecular and Translational Imaging at the European Congress of Radiology 2019.

Read Prof. Cyran’s CV here.

Harun Ilhan (Munich, Germany)

Dr. med. Harun Ilhan is a Senior Physician at the Department of Nuclear Medicine, LMU Munich.

He finished med school at the LMU Munich in 2011 and started his professional training at the Department of Nuclear Medicine, LMU Munich in 2012. His doctoral thesis focused on the evaluation of nephroprotective strategies in a murine model of radiation induced nephropathy by [Lu-177-DOTA0,TYR3]-octreotate. His habilitation topic is the concept of theranostics in nuclear medicine and focuses on the value of PET and SPECT imaging for oncology. Currently he is responsible for the nuclear medicine therapy ward with an expertise and scientific focus on peptide-receptor-radionuclide therapy using Y-90 and Lu-177 labeled somastostatin analogs and antagonists, radioligand therapy using Lu-177 labeled PSMA ligands, radioiodine therapy for thyroid cancer and radioembolization with Y-90 labeled resin microspheres.


14:30-16:00

Advanced applications in hybrid imaging

Thomas Beyer (Vienna, Austria)

Thomas Beyer holds a PhD in Physics and is co-developer of combined PET/CT imaging systems. He has a background in research and project management in academia and imaging industry.

Thomas graduated in Physics from the Leipzig University (Germany) and got his PhD in Medical Physics from Surrey University (UK). During his US-based studies he became involved in the development and clinical testing of the first PET/CT prototype (1992-2000) before joining Siemens/CTI PET Systems as an International PET/CT specialist.

In 2002 he became a Research Associate in Nuclear Medicine and Radiology and PET/CT project manager at Essen University Hospital (Germany). In 2006 he became Teaching Professor (Priv.-Doz.) for Experimental Nuclear Medicine at Essen, and joined timaq medical imaging Inc, a Zurich-based Imaging CRO. In 2007 Thomas moved to Philips Medical Systems as International Manager Clinical Science Nuclear Medicine. In 2008 he set up a Zurich-based consulting company for expert advise in cross-modality imaging and applications. He is appointed full professor of Physics of Medical Imaging at the Medical University of Vienna from March 2013.

Thomas is a member of various national and international Medicine organizations, a founding member of the European Association of Nuclear Medicine (EANM) Physics Committee, the European Society of Hybrid Imaging (ESHI) and past Head of the New Technology working group at the Association of Imaging Producers and Equipment Suppliers (AIPES).

Harun Ilhan (Munich, Germany)

Dr. med. Harun Ilhan is a Senior Physician at the Department of Nuclear Medicine, LMU Munich.

He finished med school at the LMU Munich in 2011 and started his professional training at the Department of Nuclear Medicine, LMU Munich in 2012. His doctoral thesis focused on the evaluation of nephroprotective strategies in a murine model of radiation induced nephropathy by [Lu-177-DOTA0,TYR3]-octreotate. His habilitation topic is the concept of theranostics in nuclear medicine and focuses on the value of PET and SPECT imaging for oncology. Currently he is responsible for the nuclear medicine therapy ward with an expertise and scientific focus on peptide-receptor-radionuclide therapy using Y-90 and Lu-177 labeled somastostatin analogs and antagonists, radioligand therapy using Lu-177 labeled PSMA ligands, radioiodine therapy for thyroid cancer and radioembolization with Y-90 labeled resin microspheres.

Irène Buvat (Orsay, France)

Irène Buvat received her PhD degree in “Particle and Nuclear Physics” from Paris Sud University, France, in 1992 and oriented her career towards applications of Nuclear Physics to Medical Imaging. She spent one year at University College London, UK, and two years at the National Institutes of Health, Bethesda, USA. In 1995, she entered the French “Centre National de la Recherche Scientifique”.

She is currently the head of the “In Vivo Molecular Imaging” research lab at the Service Hospitalier Frédéric Joliot PET center in Orsay, France. Her research interests focus on developing quantification methods to make the most of SPECT and PET data coupled with CT or MRI for understanding biological mechanisms or optimizing patient management. She has been the spokesperson of the worldwide OpenGATE collaboration developing the GATE Monte Carlo opensource simulation tool dedicated to emission and transmission tomography and radiotherapy applications for 10 years. She is currently largely involved in so-called radiomic approaches to further enhance the role of PET/CT and PET/MR in precision medicine. She has always been very active in training students and in knowledge and software dissemination and promotes open-access to high-standard research material.